
Dec 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Axsome Therapeutics, Ducommun and Vacasa on Tuesday.
HIGHLIGHTS
Axsome Therapeutics Inc AXSM.O: Needham raises target price to $133 from $130 |
Ducommun Inc DCO.N: RBC reinstates coverage with outperform rating |
Vacasa Inc VCSA.O: Needham cuts to hold from buy |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
Axsome Therapeutics Inc AXSM.O: Needham raises target price to $133 from $130 |
Axsome Therapeutics Inc AXSM.O: RBC raises target price to $138 from $132 |
Cal-Maine Foods Inc CALM.O: Stephens raises target price to $88 from $82 |
Ducommun Inc DCO.N: RBC reinstates coverage with outperform rating |
Ducommun Inc DCO.N: RBC reinstates coverage with price target $72 vs $60 |
Marinus Pharmaceuticals Inc MRNS.O: Baird raises target price to $0.55 from $0.50 |
Vacasa Inc VCSA.O: Needham cuts to hold from buy |
Verastem Inc VSTM.O: BTIG raises target price to $20 from $13 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))